ConductScience.org, home

Paper456408

The protein binding of methotrexate by the serum of normal subjects.

Steele WH and 3 others. Eur J Clin Pharmacol, 1979. Cited by 40 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. The protein binding of methotrexate by the serum of normal subjects. Papers, record 456408. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/456408

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The protein binding of methotrexate by the serum of normal subjects.
PubMed
Journal
Eur J Clin Pharmacol
PubMed
Year
1979
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
40
iCite
Relative citation ratio, by iCite
2.3
iCite
Revised in PubMed
2019-08-13
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Steele WHW H
2Lawrence JRJ R
3Stuart JFJ F
4McNeill CAC A

Source PubMed

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Blood ProteinsMajor topic
MethotrexateMajor topic
Humans
Kinetics
Protein Binding

Source PubMed

References21

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
15,349,626The effect of organic acids on renal clearance of methotrexate in man.Clin Pharmacol Ther1969https://conductscience.org/library/papers/5349626PubMed
21,085,404Methotrexate megadosage followed by folate rescue. I. A study in clearance patterns.Med J Aust1976https://conductscience.org/library/papers/1085404PubMed
34,539,306Recent advances in the chemotherapy of metastatic osteogenic sarcoma.Cancer1972https://conductscience.org/library/papers/4539306PubMed
44,541,737Improved therapeutic index of methotrexate with "leucovorin rescue".Cancer Res1973https://conductscience.org/library/papers/4541737PubMed
5333,910High-dose methotrexate with folinic acid rescue.Am J Hosp Pharm1977https://conductscience.org/library/papers/333910PubMed
6688,614Comparison of three radioligands, selenium-75, lodine-125, and tritium, in the radioimmunoassay of methotrexate.Clin Chem1978https://conductscience.org/library/papers/688614PubMed
74,298,056Effectiveness of high-dose infusions of methotrexate followed by leucovorin in carcinoma of the head and neck.Cancer Res1968https://conductscience.org/library/papers/4298056PubMed
8778,295Cytokinetics and chemotherapy of psoriasis.J Invest Dermatol1976https://conductscience.org/library/papers/778295PubMed
91,001,358Simple model to explain effects of plasma protein binding and tissue binding on calculated volumes of distribution, apparent elimination rate constants and clearances.Eur J Clin Pharmacol1976https://conductscience.org/library/papers/1001358PubMed
101,182,676Evaluation of methotrexate in the treatment of bronchogenic carcinoma.Cancer1975https://conductscience.org/library/papers/1182676PubMed
115,410,994Intermittent high dose oral methotrexate therapy in psoriasis.Br J Dermatol1970https://conductscience.org/library/papers/5410994PubMed
12978,453Effects of plasma protein binding of drugs on duration and intensity of pharmacological activity.J Pharm Sci1976https://conductscience.org/library/papers/978453PubMed
135,886,217Potential effect of the plasma on drug distribution.Nature1965https://conductscience.org/library/papers/5886217PubMed
144,248,129Methotrexate therapy of head and neck cancer: improvement in therapeutic index by the use of leucovorin "rescue".Cancer Res1970https://conductscience.org/library/papers/4248129PubMed
154,813,248Measurement of drug displacement by continuous ultrafiltration.J Pharm Sci1974https://conductscience.org/library/papers/4813248PubMed
1647,611The clinical pharmacology of antineoplastic agents (second of two parts).N Engl J Med1975https://conductscience.org/library/papers/47611PubMed
17856,048Effect of sodium salicylate and indomethacin on methotrexate-serum albumin binding.Arch Dermatol1977https://conductscience.org/library/papers/856048PubMed
184,954,195The metabolic fate of tritiated methotrexate. I. Absorption, excretion, and distribution in mice, rats, dogs and monkeys.Cancer Res1965https://conductscience.org/library/papers/4954195PubMed
19668,796Apparent volumes of distribution and drug binding to plasma proteins and tissues.Eur J Clin Pharmacol1978https://conductscience.org/library/papers/668796PubMed
201,107,839Binding of drugs to serum albumin (first of two parts).N Engl J Med1976https://conductscience.org/library/papers/1107839PubMed

See all 21 references

Cited by10

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 40 citations.

PMIDTitleJournalYearIn PapersSource
35,236,714Extracorporeal Treatment for Methotrexate Poisoning: Systematic Review and Recommendations from the EXTRIP Workgroup.Clin J Am Soc Nephrol2022https://conductscience.org/library/papers/35236714PubMed
21,841,039Dose-dependent disposition of methotrexate in Abcc2 and Abcc3 gene knockout murine models.Drug Metab Dispos2011https://conductscience.org/library/papers/21841039PubMed
8,793,258Thrombocytopenia in patients with rheumatoid arthritis on long-term treatment with low dose methotrexate.Clin Rheumatol1996https://conductscience.org/library/papers/8793258PubMed
8,777,850Thrombocytopenia in patients with rheumatoid arthritis on long-term treatment with low dose methotrexate.Clin Rheumatol1996https://conductscience.org/library/papers/8777850PubMed
7,628,046Pharmacokinetics of different doses of methotrexate at steady state by in situ microdialysis in a rat model.Cancer Chemother Pharmacol1995https://conductscience.org/library/papers/7628046PubMed
7,340,989The protein binding of methotrexate in the serum of patients with neoplastic disease.Cancer Chemother Pharmacol1981https://conductscience.org/library/papers/7340989PubMed
6,668,557Clearance studies of methotrexate and 7-hydroxy-methotrexate in rabbits after multiple-dose infusion.J Pharmacokinet Biopharm1983https://conductscience.org/library/papers/6668557PubMed
6,189,661Clinical pharmacokinetics of commonly used anticancer drugs.Clin Pharmacokinet1983https://conductscience.org/library/papers/6189661PubMed
3,582,482Melphalan concentration dependent plasma protein binding in healthy humans and rats.Eur J Clin Pharmacol1987https://conductscience.org/library/papers/3582482PubMed
2,191,847Antineoplastic drugs in 1990. A review (Part II).Drugs1990https://conductscience.org/library/papers/2191847PubMed

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
ALB213PubTator's text mininghttps://conductscience.org/library/genes/213

Source NCBI Gene

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/456408

GET https://conductscience.org/api/papers/v1/456408/references?page=2